4.7 Review

Hypoxia-inducible factor-1-dependent mechanisms of vascularization and vascular remodelling

Journal

CARDIOVASCULAR RESEARCH
Volume 86, Issue 2, Pages 236-242

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/cvr/cvq045

Keywords

Angiogenesis; Cell therapy; Gene therapy; HIF-1; Hypoxia; Vascularization

Funding

  1. American Diabetes Association [1-06-RA-121]
  2. NIH [R01-HL55338, P20-GM78494, P01-HL65608, N01-HV28180]
  3. Johns Hopkins Institute for Cell Engineering
  4. Chilean Ministry of Planning (MIDEPLAN)
  5. Department of Nephrology, School of Medicine, Pontificia Universidad Catolica de Chile
  6. DIVISION OF HEART AND VASCULAR DISEASES [N01HV028180] Funding Source: NIH RePORTER
  7. NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL065608, R01HL055338] Funding Source: NIH RePORTER
  8. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM078494] Funding Source: NIH RePORTER

Ask authors/readers for more resources

The vascular system delivers oxygen and nutrients to every cell in the vertebrate organism. Hypoxia-inducible factor 1 (HIF-1) is a master regulator of hypoxic/ischaemic vascular responses, driving transcriptional activation of hundreds of genes involved in vascular reactivity, angiogenesis, arteriogenesis, and the mobilization and homing of bone marrow-derived angiogenic cells. This review will focus on the pivotal role of HIF-1 in vascular homeostasis, the involvement of HIF-1 in vascular diseases, and recent advances in targeting HIF-1 for therapy in preclinical models.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available